mTOR at the nexus of nutrition, growth, ageing and disease

GY Liu, DM Sabatini - Nature reviews Molecular cell biology, 2020 - nature.com
The mTOR pathway integrates a diverse set of environmental cues, such as growth factor
signals and nutritional status, to direct eukaryotic cell growth. Over the past two and a half …

mTOR as a central hub of nutrient signalling and cell growth

J Kim, KL Guan - Nature cell biology, 2019 - nature.com
The highly conserved protein kinase mechanistic target of rapamycin (mTOR; originally
known as mammalian target of rapamycin) is a central cell growth regulator connecting …

[PDF][PDF] mTOR signaling in growth, metabolism, and disease

RA Saxton, DM Sabatini - Cell, 2017 - cell.com
The mechanistic target of rapamycin (mTOR) coordinates eukaryotic cell growth and
metabolism with environmental inputs, including nutrients and growth factors. Extensive …

The relation between PI3K/AKT signalling pathway and cancer

S Noorolyai, N Shajari, E Baghbani, S Sadreddini… - Gene, 2019 - Elsevier
Abstract Phosphatidylinositol 3-kinases (PI3Ks) are crucial coordinators of intracellular
signalling in response to the extracellular stimulators. Hyperactivation of PI3K signalling …

The role of mTOR signaling as a therapeutic target in cancer

NV Popova, M Jücker - International Journal of Molecular Sciences, 2021 - mdpi.com
The aim of this review was to summarize current available information about the role of
phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling …

PI3K/AKT signaling pathway and cancer: an updated review

M Martini, MC De Santis, L Braccini, F Gulluni… - Annals of …, 2014 - Taylor & Francis
Despite development of novel agents targeting oncogenic pathways, matching targeted
therapies to the genetic status of individual tumors is proving to be a daunting task for …

PI3K and cancer: lessons, challenges and opportunities

DA Fruman, C Rommel - Nature reviews Drug discovery, 2014 - nature.com
The central role of phosphoinositide 3-kinase (PI3K) activation in tumour cell biology has
prompted a sizeable effort to target PI3K and/or downstream kinases such as AKT and …

PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment

A Guerrero-Zotano, IA Mayer, CL Arteaga - Cancer and Metastasis …, 2016 - Springer
Anti-cancer cancer-targeted therapies are designed to exploit a particular vulnerability in the
tumor, which in most cases results from its dependence on an oncogene and/or loss of a …

Targeting the biology of aging with mTOR inhibitors

JB Mannick, DW Lamming - Nature aging, 2023 - nature.com
Inhibition of the protein kinase mechanistic target of rapamycin (mTOR) with the Food and
Drug Administration (FDA)-approved therapeutic rapamycin promotes health and longevity …

Targeting PI3K/AKT/mTOR signaling pathway in breast cancer

H Li, L Prever, E Hirsch, F Gulluni - Cancers, 2021 - mdpi.com
Simple Summary PI3K signaling pathway plays an essential role in many cellular processes
and is frequently altered in breast cancer, leading to increased tumor growth and reduced …